FindTrial
Sign In

A study on the perioperative blood loss and postoperative adverse event rate of Tibetan patients undergoing total joint arthroplasty

A study on the perioperative blood loss and postoperative adverse event rate of Tibetan patients undergoing total joint arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065336
Enrollment
Unknown
Registered
2022-11-02
Start date
2022-11-05
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis

Interventions

High altitude Tibetans:altitude
low altitude Tibetans:altitude
High-altitude Han Chinese:ethnicity
low-altitude Han Chinese:ethnicity

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with hip/knee osteoarthritis include: hip osteoarthritis, congenital hip dysplasia (Crowe type I-II), femoral head necrosis, knee osteoarthritis, etc.; 2. Patients who underwent total hip/knee arthroplasty in the Department of Orthopedics and Joint of our hospital; 3. Hemodynamic stability during and after surgery.

Exclusion criteria

Exclusion criteria: 1. Hip and knee joint infection in the past or before surgery; 2. Complicated with severe anemia or abnormal coagulation; 3. Use anticoagulants or antiplatelet drugs.

Design outcomes

Primary

MeasureTime frame
complications;perioperative blood loss;Hip/knee function;—

Secondary

MeasureTime frame
hemoglobin;hematocrit;—

Countries

China

Contacts

Public ContactHuang Qiang

West China Hospital of Sichuan University

huangqiang4325@126.com+86 18980606708

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026